Joining the global race to find solutions to the ongoing SARS-CoV-2 pandemic, IGY Life Sciences is developing one of the first polyclonal antibodies for the treatment of COVID-19. IGY-110 is an ...

Most antibodies used by researchers are either polyclonal — a mixture of antibodies derived from the serum of immunized animals — or monoclonal, where a single specific clone comprises the ...

Learn about our Editorial Policies. Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are highly specific to ...

Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

Introduction Therapeutic antibodies are laboratory-engineered proteins designed to replicate the immune system's natural ability to combat dise ...

A technique invented by the lab, known as Electron Microscopy-Based Polyclonal Epitope Mapping (EMPEM), lets the researchers see exactly where on the HIV virus antibodies bind. When they carried ...

A technique invented by the lab, known as Electron Microscopy-Based Polyclonal Epitope Mapping (EMPEM), lets the researchers see exactly where on the HIV virus antibodies bind. When they carried ...